[Form 4] Encompass Health Corporation Insider Trading Activity
Encompass Health Corp (EHC) insider Patrick W. Tuer, EVP and Chief Operating Officer, reported a sale of 1,020 shares of Encompass Health common stock on 08/27/2025 at a reported price of $123.59 per share. After the transaction, Mr. Tuer beneficially owned 18,846 shares. The Form 4 was signed by an attorney-in-fact, Patrick Darby, on behalf of the reporting person.
Patrick W. Tuer, EVP e Chief Operating Officer di Encompass Health Corp (EHC), ha venduto 1.020 azioni ordinarie di Encompass Health il 27/08/2025 al prezzo riportato di $123,59 per azione. Dopo l’operazione, il signor Tuer deteneva beneficiariamente 18.846 azioni. Il Modulo 4 è stato firmato da un procuratore, Patrick Darby, per conto della persona segnalante.
Patrick W. Tuer, EVP y Director de Operaciones de Encompass Health Corp (EHC), informó la venta de 1.020 acciones ordinarias de Encompass Health el 27/08/2025 a un precio reportado de $123,59 por acción. Tras la transacción, el Sr. Tuer poseÃa beneficiariamente 18.846 acciones. El Formulario 4 fue firmado por un apoderado, Patrick Darby, en nombre del declarante.
Encompass Health Corp(EHC)ì� EVP ê²� ìµœê³ ìš´ì˜ì±…ìž„ìž�(Chief Operating Officer)ì� Patrick W. TuerëŠ� 2025-08-27ì—� Encompass Health 보통ì£� 1,020주를 주당 ë³´ê³ ê°€ê²� $123.59ì—� 매ë„했다ê³� ë³´ê³ í–ˆìŠµë‹ˆë‹¤. 거래 í›� Tuer 씨는 실질ì 으ë¡� 18,846주를 ë³´ìœ í•˜ê³ ìžˆì—ˆìŠµë‹ˆë‹�. Form 4ëŠ� ë³´ê³ ì¸ì„ ëŒ€ì‹ í•´ 변호권ì� ê°€ì§� Patrick Darbyê°€ 서명했습니다.
Patrick W. Tuer, EVP et directeur des opérations (COO) d'Encompass Health Corp (EHC), a déclaré la vente de 1�020 actions ordinaires d'Encompass Health le 27/08/2025 au prix déclaré de 123,59 $ par action. Après la transaction, M. Tuer détenait bénéficiairement 18�846 actions. Le formulaire 4 a été signé par un mandataire, Patrick Darby, au nom de la personne déclarante.
Patrick W. Tuer, EVP und Chief Operating Officer von Encompass Health Corp (EHC), meldete den Verkauf von 1.020 Stammaktien von Encompass Health am 27.08.2025 zu einem berichteten Preis von $123,59 pro Aktie. Nach der Transaktion besaß Herr Tuer wirtschaftlich 18.846 Aktien. Das Formular 4 wurde von einem Bevollmächtigten, Patrick Darby, im Namen der meldenden Person unterschrieben.
- Timely disclosure of insider transaction in compliance with Section 16
- Complete transaction details provided including date, price, amount sold, and resulting beneficial ownership
- Insider disposition: sale of 1,020 shares was reported
- No additional context (e.g., purpose of sale or aggregate holdings beyond post-transaction count) provided in the filing
Insights
TL;DR Insider sale of 1,020 shares was reported in compliance with Section 16.
The transaction is a straightforward disclosure of an insider disposition: 1,020 shares sold at $123.59, leaving 18,846 shares owned. The filing shows timely reporting and use of an attorney-in-fact to execute the form. Absent additional context on the reporting person's total holdings or recent pattern of trading, this single sale alone does not provide material information about company fundamentals.
TL;DR The Form 4 indicates compliant disclosure practices but records an insider sale that investors may note.
The filing identifies the reporting person as EVP and COO and records the sale on 08/27/2025. Signature by an attorney-in-fact is properly indicated. From a governance perspective, the form meets reporting requirements by listing the transaction type, amount, price, and resulting beneficial ownership. The filing does not disclose any derivative activity or planned trading arrangement.
Patrick W. Tuer, EVP e Chief Operating Officer di Encompass Health Corp (EHC), ha venduto 1.020 azioni ordinarie di Encompass Health il 27/08/2025 al prezzo riportato di $123,59 per azione. Dopo l’operazione, il signor Tuer deteneva beneficiariamente 18.846 azioni. Il Modulo 4 è stato firmato da un procuratore, Patrick Darby, per conto della persona segnalante.
Patrick W. Tuer, EVP y Director de Operaciones de Encompass Health Corp (EHC), informó la venta de 1.020 acciones ordinarias de Encompass Health el 27/08/2025 a un precio reportado de $123,59 por acción. Tras la transacción, el Sr. Tuer poseÃa beneficiariamente 18.846 acciones. El Formulario 4 fue firmado por un apoderado, Patrick Darby, en nombre del declarante.
Encompass Health Corp(EHC)ì� EVP ê²� ìµœê³ ìš´ì˜ì±…ìž„ìž�(Chief Operating Officer)ì� Patrick W. TuerëŠ� 2025-08-27ì—� Encompass Health 보통ì£� 1,020주를 주당 ë³´ê³ ê°€ê²� $123.59ì—� 매ë„했다ê³� ë³´ê³ í–ˆìŠµë‹ˆë‹¤. 거래 í›� Tuer 씨는 실질ì 으ë¡� 18,846주를 ë³´ìœ í•˜ê³ ìžˆì—ˆìŠµë‹ˆë‹�. Form 4ëŠ� ë³´ê³ ì¸ì„ ëŒ€ì‹ í•´ 변호권ì� ê°€ì§� Patrick Darbyê°€ 서명했습니다.
Patrick W. Tuer, EVP et directeur des opérations (COO) d'Encompass Health Corp (EHC), a déclaré la vente de 1�020 actions ordinaires d'Encompass Health le 27/08/2025 au prix déclaré de 123,59 $ par action. Après la transaction, M. Tuer détenait bénéficiairement 18�846 actions. Le formulaire 4 a été signé par un mandataire, Patrick Darby, au nom de la personne déclarante.
Patrick W. Tuer, EVP und Chief Operating Officer von Encompass Health Corp (EHC), meldete den Verkauf von 1.020 Stammaktien von Encompass Health am 27.08.2025 zu einem berichteten Preis von $123,59 pro Aktie. Nach der Transaktion besaß Herr Tuer wirtschaftlich 18.846 Aktien. Das Formular 4 wurde von einem Bevollmächtigten, Patrick Darby, im Namen der meldenden Person unterschrieben.